pubmed-article:9655601 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9655601 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:9655601 | lifeskim:mentions | umls-concept:C0002395 | lld:lifeskim |
pubmed-article:9655601 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
pubmed-article:9655601 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
pubmed-article:9655601 | lifeskim:mentions | umls-concept:C0063390 | lld:lifeskim |
pubmed-article:9655601 | pubmed:issue | 2-3 | lld:pubmed |
pubmed-article:9655601 | pubmed:dateCreated | 1998-10-6 | lld:pubmed |
pubmed-article:9655601 | pubmed:abstractText | Imidazoline receptors (29/30- and 45-kDa proteins) were quantitated in postmortem brains of patients with Alzheimer's disease (AD) by using immunoblotting techniques and a specific antiserum. Increased levels of the 29/30-kDa protein (30%), 45-kDa protein (36%) and glial fibrillary acidic protein (88%) were found in the frontal cortex of AD patients. These findings are in line with the reported higher density of imidazoline receptors labelled by [3H]idazoxan in AD brains, suggesting that these imidazoline receptor proteins are related to the I2-imidazoline receptor located in mitochondria of glial (astrocyte) cells. | lld:pubmed |
pubmed-article:9655601 | pubmed:language | eng | lld:pubmed |
pubmed-article:9655601 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9655601 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9655601 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9655601 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9655601 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9655601 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9655601 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9655601 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9655601 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9655601 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9655601 | pubmed:month | May | lld:pubmed |
pubmed-article:9655601 | pubmed:issn | 0304-3940 | lld:pubmed |
pubmed-article:9655601 | pubmed:author | pubmed-author:BourasCC | lld:pubmed |
pubmed-article:9655601 | pubmed:author | pubmed-author:WalzerCC | lld:pubmed |
pubmed-article:9655601 | pubmed:author | pubmed-author:GuimónJJ | lld:pubmed |
pubmed-article:9655601 | pubmed:author | pubmed-author:García-Sevill... | lld:pubmed |
pubmed-article:9655601 | pubmed:author | pubmed-author:EscribáP VPV | lld:pubmed |
pubmed-article:9655601 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9655601 | pubmed:day | 15 | lld:pubmed |
pubmed-article:9655601 | pubmed:volume | 247 | lld:pubmed |
pubmed-article:9655601 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9655601 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9655601 | pubmed:pagination | 95-8 | lld:pubmed |
pubmed-article:9655601 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:9655601 | pubmed:meshHeading | pubmed-meshheading:9655601-... | lld:pubmed |
pubmed-article:9655601 | pubmed:meshHeading | pubmed-meshheading:9655601-... | lld:pubmed |
pubmed-article:9655601 | pubmed:meshHeading | pubmed-meshheading:9655601-... | lld:pubmed |
pubmed-article:9655601 | pubmed:meshHeading | pubmed-meshheading:9655601-... | lld:pubmed |
pubmed-article:9655601 | pubmed:meshHeading | pubmed-meshheading:9655601-... | lld:pubmed |
pubmed-article:9655601 | pubmed:meshHeading | pubmed-meshheading:9655601-... | lld:pubmed |
pubmed-article:9655601 | pubmed:meshHeading | pubmed-meshheading:9655601-... | lld:pubmed |
pubmed-article:9655601 | pubmed:meshHeading | pubmed-meshheading:9655601-... | lld:pubmed |
pubmed-article:9655601 | pubmed:meshHeading | pubmed-meshheading:9655601-... | lld:pubmed |
pubmed-article:9655601 | pubmed:meshHeading | pubmed-meshheading:9655601-... | lld:pubmed |
pubmed-article:9655601 | pubmed:meshHeading | pubmed-meshheading:9655601-... | lld:pubmed |
pubmed-article:9655601 | pubmed:meshHeading | pubmed-meshheading:9655601-... | lld:pubmed |
pubmed-article:9655601 | pubmed:meshHeading | pubmed-meshheading:9655601-... | lld:pubmed |
pubmed-article:9655601 | pubmed:meshHeading | pubmed-meshheading:9655601-... | lld:pubmed |
pubmed-article:9655601 | pubmed:meshHeading | pubmed-meshheading:9655601-... | lld:pubmed |
pubmed-article:9655601 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9655601 | pubmed:articleTitle | Imidazoline receptor proteins in brains of patients with Alzheimer's disease. | lld:pubmed |
pubmed-article:9655601 | pubmed:affiliation | Department of Psychiatry, Faculty of Medicine, University of Geneva, H.U.G., Chêne-Bourg, Switzerland. | lld:pubmed |
pubmed-article:9655601 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9655601 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9655601 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9655601 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9655601 | lld:pubmed |